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Abstract. Implementation of optogenetic techniques is a recent addition to the neuroscientists’ preclinical
research arsenal, helping to expose the intricate connectivity of the brain and allowing for on-demand direct
modulation of specific neural pathways. Developing an optogenetic system requires thorough investigation
of the optogenetic technique and of previously fabricated devices, which this review accommodates. Many
experiments utilize bench-top systems that are bulky, expensive, and necessitate tethering to the animal.
However, these bench-top systems can make use of power-demanding technologies, such as concurrent elec-
trical recording. Newer portable microdevices and implantable systems carried by freely moving animals are
being fabricated that take advantage of wireless energy harvesting to power a system and allow for natural
movements that are vital for behavioral testing and analysis. An investigation of the evolution of tethered, port-
able, and implantable optogenetic microdevices is presented, and an analysis of benefits and detriments of each
system, including optical power output, device dimensions, electrode width, and weight is given. Opsins, light
sources, and optical fiber coupling are also discussed to optimize device parameters and maximize efficiency
from the light source to the fiber, respectively. These attributes are important considerations when designing and
developing improved optogenetic microdevices. © 2015 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1
.NPh.2.3.031206]
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1 Introduction
The introduction of targeted photostimulation on opsin-express-
ing neuronal cells provides the potential to transform our insight
into the neural circuitry associated with complex behaviors. In
particular, research on treatment of psychiatric mood disorders
is expected to benefit from optogenetic techniques.1–4 More
broadly, neuroscience will benefit, and preclinical psychiatric
research models stand to gain much through this approach.
This may aid in our comprehension of how conscious behaviors
are altered through pathway modulations that resemble disease
states.5,6 Furthermore, conventional treatment options have lim-
ited efficacy and significant side-effects, and the development of
novel therapies is dependent on advances in neurobiology to
identify druggable targets.7,8 Therefore, in order to both under-
stand the brain’s complexity and determine safe treatment
methods, it is necessary to advance behavioral research by
modulating brain activity through the optogenetic method in
appropriate animal models. However, caveats exist to conven-
tional benchtop optogenetic systems in that they are bulky,
expensive, inefficient, and require the animal to be tethered to
receive photostimulation.
Tethering of the animal is one particular limitation of current
optogenetic systems. Tethering increases experimental risks due
to tangling of the optical fiber cord around the animal or through
the experience of unintended rotational forces when connected.
These issues confound natural behaviors that are essential for
interpreting behavioral data. In general, behavioral tests should
mimic previously validated studies rather than be unnecessarily
modified.9 Having these established comparisons allows
researchers to better correlate behaviors with the induced neural
modulations. In the optogenetic technique, tethering the animal
to the benchtop light source and control system substantially
reduces the reproducibility of validated behavioral tests. One
solution to this issue is to miniaturize the entire system such
that photostimulation can be controlled and delivered through
a wearable or implanted microdevice, ensuring minimal behav-
ioral disturbances originate from the optogenetic system.
Despite the advantages for investigators to utilize a portable
optogenetic system for neuromodulation research, the complex-
ities in developing these microdevices necessitate advanced fab-
rication techniques and novel electronic components. Another
difficulty arises when optimizing the coupling efficiency
between the light source and the optical fiber to deliver adequate
light power output while minimizing energy consumption.
Therefore, many research groups continue to evolve tethered
systems, focusing advances on unique optical electrodes and
recording capabilities. As many research groups aim to develop
their own device for their specific research protocols, taking an
optogenetic microdevice from conception to production requires
an extensive examination of both previously developed devices
and cutting-edge technologies that can be implemented. To do
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this effectively, a current investigation of tethered, portable, and
implantable devices is required for the analysis of the techno-
logical direction that these devices are taking, the studies they
are facilitating, the advanced components each utilizes, as well
as important parameters critical to each of their designs.
2 Optogenetics
2.1 Opsins
Optogenetics induces modulations in the activity of transfected
neurons that express opsins on their membrane surface. When
activated by light, these opsins function as channels that allow
passage of specific ions to either depolarize or hyperpolarize the
cell, affecting signal transmission. The result is the ability to
control activation patterns of specific transfected cells through
light delivery.10 Viral vectors are commonly used to transfect
neurons in vivo. The virus is modified to only target certain
cell types, for example, only those cells with Cre-positive
expression.11 Once targeted, the virus splices the opsin-encoding
DNA into the neuronal cell genome at the site of virus injection.
Global opsin expression can alternatively be accomplished
by genetically engineering transgenic animals. Each type of
opsin has unique properties in terms of which ions it gates
and what wavelengths activate it. Opsins commonly used for
optogenetics research include halorhodopsin, channelrhodopsin,
and archaerhodopsin (Table 1). Here we include the optimal
activation wavelength for these opsins, as well as their effective
power density for 50% activation (EPD50). EPD50 measures
photostimulation sensitivity of opsins independent of opsin
expression levels, indicating how much optical output an
optogenetic system needs to activate certain opsin types. With
advances in genetic engineering, opsins can be developed to
respond to a wider range of stimulation parameters, function
through unique gating types, and have different sensitivities to
light. Opsins have traditionally acted as channels to change ionic
concentrations inside the cell. Opsins have also been engineered
to activate second messenger systems, such as the OptoXR’s
Opto-α1AR (IP3, DAG Recruiting GPCR) and Opto-β2AR
(cAMP Recruiter GPCR), which both activate at 473 nm.12
2.2 Light Sources
Optimizing light sources and a delivery system is necessary to
activate opsins at the region of interest, as optical penetration
through brain tissue is relatively low from the cortical surface.
Therefore, in order to modulate deeper brain regions, the light
beam would need to be sufficiently strong at the site of stimu-
lation. This is typically achieved through the use of optical
fibers, but miniature light sources implanted into the brain
can also be used. The light source must be powerful enough
to penetrate enough tissue volume and stimulate the entire
region of interest. Modeling light transmission through brain
slices aids in determining how much light is required and can
be calculated using the Kubelka-Munk equation for diffuse scat-
tering media.
T ¼ 1ðS × zÞ þ 1 ; (1)
where T is the transmission fraction, S is the scattering coeffi-
cient per unit thickness, and z is the thickness of the sample.19
This simplified model demonstrates that transmission efficiency
is inversely proportional to the scattering coefficient. Among the
visible light spectrum (∼400 to 900 nm), transmission loss from
scattering is much greater than transmission loss from tissue
absorption.20,21 This implies that the tissue scattering coefficient
is an important indicator of light transmission through the brain
tissue. For mice, the best fit scattering coefficient is 11.2 mm−1,
while for rats, the best fit scattering coefficient is 10.3 mm−1.15
Aravanis et al. measured a 50% reduction in fiber-coupled
optical power through 100 μm of brain tissue penetration that
increased to 90% after 1 mm of tissue depth using a 20 mW
laser diode system.15 Laser systems penetrate through tissue
with greater efficiency due to their low angle of incidence and
high numerical aperture (see Sec. 2.3). The light exiting this
200 μm multimodal fiber outputs is considerably high at
∼380 mW∕mm2 and spreads at an angle of 32 degwith a numeri-
cal aperture of 0.37. Neuronal activation is achievable at least
1.4 mm from the fiber tip, where optical power is at least
1 mW∕mm2 and covers a 1 mm diameter cross-section. With
such high levels of tissue penetration and optical power, laser-
based systems have proven useful in early optogenetic experi-
ments. The first experiments demonstrating neuronal activation
through a light source were performed in 1971 by Richard
Fork using a 488 nm blue laser light at Bell laboratories.22
Their experiments required an extremely high level of irradiance
(140 mW∕mm2), achievable through laser systems, to activate
native abdominal ganglia of marine mollusks. Karl Deisseroth,
who coined the term “optogenetics,” first demonstrated millisec-
ond-timescale activity control of Channelrhodopsin-2 (ChR-2)
transfected mammalian cells using a 300 W xenon lamp in
2005.16 Since then, several light delivery devices have been intro-
duced, including light-emitting diodes (LEDs), organic LEDs
(OLEDs), liquid crystal displays (LCDs), halogen lights, and arc
lamps.More recent systems have adoptedLEDsystems over laser
systems due to benefits in price, instrument size, beam stability,
Table 1 Characteristics and parameters of various opsins used in optogenetics.
Opsin type Opsin subfamily Gate type Activation λ (nm) EPD50 (Ref. 13)
Channelrhodopsin ChR-2 Cation channel 46014–16 1.3 mW∕mm2
Channelrhodopsin VChR1 Cation channel 58917,18 ∼0.5 mW∕mm2
Halorhodopsin eNpHR3.0 Chloride pump 58913 5.4 mW∕mm2
Archaerhodopsin Arch Proton pump 56612 ∼7.5 mW∕mm2
Note: EPD50, effective power density for 50% activation.
Neurophotonics 031206-2 Jul–Sep 2015 • Vol. 2(3)
Kale et al.: Evolution of optogenetic microdevices
Downloaded From: http://neurophotonics.spiedigitallibrary.org/ on 10/19/2015 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
and high frequency temporal precision.23 Despite the high power
intensities achievable through laser-based systems, sufficient
levels to activate ChR-2 proteins with 470 nm photostimulation
are modest, with the minimum spiking irradiance being between
0.1 and 1 mW∕mm2 (or 106 to 107cd∕mm2).24 At intensities
<0.1 mW∕mm2, ChR-2 response falls below 10%.25 High-inten-
sity light sources, such as arc lamps16,26 and lasers,15,27,28,29 can
achieve these optical outputs, as well as many LEDs;30–32 how-
ever, their function is limited to single-point illumination and
whole-field illumination. OLEDs and LCDs, on the other
hand, produce greater spatial resolution on two-dimensional
arrays, but fall short on providing adequate irradiance for photo-
activation (on the order of 1 × 10−4 mW∕mm2, three orders of
magnitude too low to activate ChR-2).33Many newer optogenetic
systems rely on LED light such as that developed by Clements
et al.23 Their LED optogenetic system delivers adequate photo-
stimulation to ChR-2 transfected neurons in mice to induce a
freeze behavioral response,with peak light output from the device
measuring at 29.6 mW through a 465 nm LED. With a total time
lag of 328 microseconds from the trigger to 90% peak output,
this LED-based device ensures the reliable temporal precision
necessary for optogenetic stimulation parameters.
Photostimulation, especially with LEDs, has the benefit of
producing relatively low stimulation artifacts during simultane-
ous neural recording. In contrast, when electrical recording
devices are used with deep brain stimulation, large stimulation
artifacts are present during pulse delivery. These recording
systems include electroencephalogram recordings,34 evoked
potential recording,35,36 local field potential recording,37 and
single neuron recording.38 Each of these recording techniques
needs to actively control artifact suppression through filtering
and other methods to optimize signal-to-noise ratio during
electrical stimulation. Three sources of stimulus artifacts can
be identified at the recording electrode, including voltage gra-
dients, common-mode conversion, and capacitive coupling.39,40
However, an analysis by Clements et al.23 of electrical recording
during optogenetic stimulation revealed stimulation-induced
noise that occurred at microvolt-scale detection levels compared
to much larger millivolt-sized neuronal signals.23 Therefore, the
perturbations of optogenetic stimulation artifacts are dwarfed by
the electrical signals generated by the cells. These artifacts
were recorded using a multielectrode array (platinum-iridium,
pure iridium, tungsten); however, these low-frequency optical
artifacts can also be picked up by electroencephalogram record-
ings or by local field potential electrodes.41 Low-frequency
artifacts can be produced by a variety of processes ranging
from temperature kinetics changing the electrode conductance
to direct illumination of the metal electrode causing electron
emissions (known as the photoelectric effect).42 These particular
artifacts can be removed through high-pass filtering of the
signal.29
Delivering enough optical power to the site of stimulation is
imperative and requires powerful light sources and efficient
delivery systems. However, other parameters such as pulse
width and frequency of light pulses are important characteristics
of optogenetic stimulation parameters that need to be estab-
lished for each study. Generally, a pulse width range of
100 μs to 10 ms and a pulse frequency up to 200 Hz covers
the operating spectrum of optogenetic research.43 These param-
eters, however, are specific to the neuronal cell type, the
expressed opsin, and the activation patterns specified for the
experiment, and can vary greatly between experimental designs.
Determining the ideal parameters for an optogenetics study
requires extensive research and experimentation.
2.3 Fiber Coupling
One of the challenges in building a novel optogenetic microde-
vice is deciding on an interface to optimally transmit light from
the LED source to the neuronal tissue. Because power consump-
tion is a major concern with both battery-based and energy-har-
vesting systems, the interface coupling should be as efficient
as possible to reduce electrical demands. Some authors cited
in this paper are satisfied with cortical surface stimulation to
validate their device. However, most behavioral neuromodula-
tion research focuses on deeper brain structures and requires
a delivery method for the light. Optical fiber coupling is, there-
fore, an appropriate solution, as optical fiber materials effi-
ciently transport light while being biocompatible and inert to
organic tissue. Although some tissue damage does occur from
optical fiber insertion, a relatively small “kill zone” is created
when using small-diameter inert materials.44 Smaller-diameter
optical fibers are more preferable than larger ones because they
minimize neural necrosis along the insertion tract, as well as the
resulting inflammatory response.45 However, smaller fibers trans-
mit light less efficiently because of their more restrictive fiber
cores. In rodents, fiber diameters of up to 300 μm can be tolerated
by mice, while up to 400 μm can be tolerated by rats.46
Maximizing the coupling efficiency between the LED and
the optical fiber is important but can be difficult due to the
incredibly small optical fiber core compared with most source
LEDs. Typical LEDs fall in the hundreds of micrometers to
millimeter range, while micro-LEDs (μLEDs) are in the tens
of micrometers range.33,47,48 Although the dimensions of most
μLEDs are comparable in size to the diameter of an optical
fiber core, transmission efficiency is dependent on many factors
including the LED’s angle of incidence. A smaller core allows
for less incident light to enter and accepts only smaller angles
that propagate from the source. Therefore, multimodal optical
fibers, which have much larger core diameters compared with
single-mode fibers, offer better light transmission. A higher
numerical aperture (NA) will also offer better coupling effi-
ciency as it allows less light to escape through the fiber cladding
once it has entered the core. The NA can be defined as
NA ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n2core − n2clad
q
; (2)
where ncore is the refractive index of the core, and nclad is the
refractive index of the cladding around the core. The NA is,
therefore, an important value to define the light-gathering capac-
ity of the fiber.49 Using a lens also aids in focusing the light
directly into the fiber; however, this increases the dimensions
of the microdevice, as spacing is needed between the lens and
the fiber equivalent to the focal length of the lens. Many cost-
effective lenses in the market have relatively large focal lengths
(∼3 mm), while lenses made of more sophisticated materials
have smaller focal lengths but can be costly. Lenses can greatly
increase the coupling efficiency of the light to the fiber as shown
by the following equation:
η ¼

NAðfiberÞ
NAðlensÞ

2
; (3)
where η is the coupling efficiency. This equation demonstrates
that the coupling efficiency can be increased with a lens as long
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as the NA of the fiber is greater than the NA of the lens
Typically, it is important to consider lenses with a refractive
index of 1.9 or greater; otherwise, the peak coupling efficiency
becomes equal to butt-coupling.50
Conventional methods for light delivery rely on acute optical
fiber stimulation, where the optical fiber can be inserted and
removed. The fiber is inserted only when the stimulation is
required, for example, during behavioral testing.15 This design
makes use of permanently fixed cannulas,15 such as those avail-
able from Doric Lenses.51 These cannulas are patched to min-
imize infection of exposed neural tissue, but can be opened
whenever a fiber needs to be inserted for experimentation.
The drawbacks from this method are apparent, in that continu-
ous reinsertion of the fiber can increase the likelihood of
breaking the fiber and clogging the cannula,46 as well as slightly
changing the placement of the stimulation site and altering
different neuronal activities during each fiber placement.50 In
contrast, permanently fixing only the optical fiber into the
brain without using a cannula leads to less tissue damage during
chronic behavioral experiments due to the thinner implant.50,52
Many researchers use only a short fiber segment that is perma-
nently implanted into the brain.53 When stimulation is needed, a
fiber-to-fiber connector can couple this segment to a longer fiber
that is connected to the light source. However, this connector
can result in up to a 50% loss in transmission efficiency and,
therefore, requires a powerful light source. Some limitations to
this approach do exist, such as unintended escaping of LED
light acting as a behavioral cue during stimulation.54,55
3 Devices
3.1 Tethered Systems
The optogenetic system by Clements et al.23 is a tethered device.
This means that throughout light delivery, the animal must be
connected by an optical fiber cord to a light source that is exter-
nal to the animal’s testing environment, as shown in Figs. 1(a)
and 1(b). Tethered systems typically face a problem with tan-
gling between the optical fiber cord and the animal, especially
if more than one animal is needed to study social behaviors. A
rotary connector can be used to ensure free-moving behavior
and uninterrupted optical connection within an open-topped
behavioral apparatus, but they restrict experiments that require
an enclosed home-cage top.56 Although a rotary connector
seems to be an ideal solution for tethered experiments, it causes
continuous pulling forces on the animal due to retraction of the
cord, and frictional torques during animal rotations. Careful
consideration of the animal species is important when using
a rotary connector, as mice are able to withstand torques of
up to 150 μN · m, while rats can exceed torque tolerations of
>300 μN · m.57 Therefore, optimization of pulling forces by
the rotary connector is necessary to keep the cord taunt without
causing unnecessary cord retracting stress to the animal. Despite
achieving rotary optimization, tethering can still alter behavior
and disrupt the naturalistic testing environment being sought,
potentially confounding behavioral experiments. Another
issue with the use of rotary connectors is the transmission effi-
ciency of the light source. Some commercially available rotaries
yield relatively high transmission efficiencies, while some give
much less (Prizmatix: 89%, Doric Lenses: 85%, ThorLabs:
65%). Tethered systems are not limited by the electrical
demands of their light source and can, therefore, deliver higher
optical power. Compared with portable devices, which are
restricted by their power supply and energy consumption, rotary
connectors do benefit an experiment when tethering cannot be
avoided.
Another function that can be conducted concurrently with
photostimulation is neuronal recording. Recording the electrical
signals of neurons produced by optogenetic stimulation gives
insight into the robustness of the photostimulation response
and subsequent spatial activity changes. Confirmation of con-
tinuous neuromodulation by the optogenetic system is achieved
through these recording electrodes, providing both temporal and
spatial information. Single recording electrode implants can
measure the effectiveness of the optogenetic device and are,
therefore, important tools to validate the device’s functionality.
Multielectrode arrays can measure the distribution of neuronal
activation from the light beam as it disperses out of the fiber
and into the tissue. This is because of the two-dimensional
spatial recording abilities of multielectrode arrays. Previous
applications of multielectrode arrays include neural network
dynamics,59 synaptic plasticity,60 visual perception,61 and phar-
macotherapies.62 Because optical transmission decreases as the
light passes through neural tissue [as shown by Eq. (1)], multiple
recording electrodes can help determine how much area of
activation is produced by the photostimulation. This is a useful
tool to ensure that a specific brain region of interest can achieve
the desired spatial coverage to ensure complete stimulation.
Although each recording electrode on the array can be replaced
with an electrical stimulator, conventional stimulation arrays are
only able to stimulate, and not inhibit electrical activity.
Current technology allows for multielectrode arrays to be fit-
ted with single optical fibers such as that by Wang et al.58 As
shown in Figs. 1(c) and 1(d), a Pt-tipped 6 × 6 multielectrode
array tapered to 1 mm length with 400 μm spacing was used
to provide verification that electrical activity was modulated
locally in response to the light. Additionally, this system can
be adapted with closed-loop control features to set stimulation
triggers based on surrounding activity. These triggers ensure
that activity is modulated only when certain neural criteria
are met, helping to achieve the relevant behaviors at optimized
Fig. 1 (a) and (b) Optogenetic system by Clements et al.23 with a teth-
ered animal. (c) and (d) A multielectrode and optrode array by Wang
et al.58 capable of recording and stimulating a tethered animal.
[Source: (a) and (b) reprinted from Clements et al.23 with permission
from SPIE. (c) and (d) reproduced with permission fromWang et al.,58
Copyright year 2012, IOP Publishing. All rights reserved.]
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times without overstimulating the brain. This is an important
control feature in attenuating neurobiological diseases in animal
models, such as epilepsy, because they can be turned on as soon
as seizure-like waveforms are detected.63–65 However, one
drawback that can arise with such multielectrode arrays is that
multiple deep penetration points can cause brain injury during
insertion, especially when trying to stimulate and record from
deeper brain regions. Each recording electrode in the array
can be hundreds of micrometers in diameter, and each causes
neuronal damage as the array is driven into the brain. For
this reason, most studies using multielectrode arrays restrict
their measurements to cortical recording. The recording array
of Wang et al.,58 for example, only penetrated 0.5 to 1 mm
into the brain. This kind of invasive surgery can trigger a pro-
longed inflammatory and immune response66 that could sub-
sequently affect neural activity and confound behavior.
To avoid multiple penetration points during insertion of the
optical fiber and recording electrodes, as well as to record from
deeper brain regions, a solution is to combine the electrode and
LED onto a biocompatible material as a single piece, commonly
referred to as an optrode, and insert this into the desired region.
This combined optrode can simultaneously stimulate and record
from the same site and is a feature in the optogenetic system
fabricated by Cao et al.67 The team incorporated the LED and
electrode onto a single optrode for dual stimulation and record-
ing as shown in Figs. 2(a) and 2(b). Their design minimizes
power consumption by allowing full exposure of the LED to
the stimulation site without losing efficiency through optical
fiber coupling. This particular optrode is relatively wide,
measuring 900 μm. In contrast, commercially available optical
fibers for preclinical research are between 200 and 400 μm.
The system of Cao et al.67 also uses a particularly large
LED, measuring 1000 μm×600 μm×200 μm (PicoLED, Rohm
Semiconductor, Kyoto, Japan). However, technology is contin-
uously advancing to produce smaller and more efficient LEDs
that may be implemented in future designs. With advanced fab-
rication technologies and components, this device has potential
to be reduced in size for less traumatic implantation. Early optr-
odes for tethered freely moving experiments were first devel-
oped by Anikeeva et al.68 to record medial prefrontal cortex
response by local optical excitation and inhibition. Their group
produced four 25-μm-diameter polymer-coated nickel-chro-
mium alloy tetrode bundles that wound around a single 200 μm
optical fiber. The optrode was attached to a headstage to allow
open-field movement while tethered to the light source.
In their experiment, Cao et al.67 bypassed the ChR-2 trans-
fection process by procuring a transgenic Thy1-ChR2-YFP
mouse line. While anesthetized and in stereotaxis, the mouse
received blue light at 465 nm to the visual cortex created by an
LED, which changed neuronal electrophysiology monitored by
the recording optrode. Using transgenic animals can be advanta-
geous in that the opsin molecules are persistently expressed
throughout the brain. Unfortunately, obtaining such transgenic
animals requires greater resources and time than utilizing the
transfection process, as transgenic animals need to be geneti-
cally engineered and bred for several generations. Therefore, in
most cases, recombinant viral vectors are used to administer the
virus several weeks prior to the optrode insertion at the site of
Fig. 2 (a) and (b) An optrode fabricated by Cao et al.67 for dual stimulation and recording from a single
site. (c) and (d) An intricate recording/stimulating optrode by Rubehn et al.69 with a microfluidic channel
capable of delivering a virus for neural transfection. [Source: (a) and (b) are reprinted from Cao et al.67
with permission from IEEE. (c) and (d) are reprinted from Rubehn et al.69 with permission from Royal
Society of Chemistry.]
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stimulation. The virus is typically administered by direct injec-
tion into the brain region of interest using a micro-syringe. The
optrode is then implanted into the same spot after the virus is
completely transfected. This double-surgery approach, however,
adds surgical stress to the animal through anesthesia induction.
Although unavoidable in most nontransgenic animals, the initial
transfection surgery would have relatively little consequence in
neurodegeneration because neuronal loss and the glial-inflam-
mation response are considerably higher with persistent foreign
body implantation than acute stab wounds followed by object
removal.70 In general, glial response is biphasic with an early
activation of microglia and astrocytes followed by a restriction
of glial activity at the site closest to the implant (glial scarring).71
Nevertheless, maintaining opsin expression at the site of stimu-
lation can be difficult after the optrode has been implanted.
When retransfection is necessary for longer experiments, a con-
tinuous local viral transfection can be accomplished through the
implementation of microfabrication techniques and microfluidics.
Advances in microelectromechanical systems fabrication
techniques have allowed scientists to shrink down medical devi-
ces to the size of tiny chips. Lab-on-chip devices utilize micro-
fluidic channels to transport fluids to specific targets in order to
perform extensive laboratory-grade research in tiny settings.
Rubehn et al.69 have incorporated this technology to deliver
the soluble virus through microfluidic channels while also per-
forming optical stimulation and electrical recording on one sin-
gle microfluidic optrode, as shown in Figs. 2(c) and 2(d). Not
only does this allow a single invasive surgery to accomplish both
transfection and stimulation, it also enables microfluidic injec-
tion of the virus for on-demand, continuous transfection. This is
because cellular expression of virally transfected opsins dimin-
ishes over time, therefore, experimental timelines need to be
kept shorter or retransfection needs to take place. Once suffi-
cient time has elapsed to ensure recombinant viral transfection,
optical stimulation can begin to modulate neural activity and
concurrent electrical recording can take place. With such precise
fabrication processes, this fluidic delivery optrode hybrid has a
thickness of ∼250 μm, about the same thickness as many optical
fibers used. However, manufacturing such an optrode is not typ-
ically possible in most laboratories, as it needs a sophisticated
fabrication process. Prior research in design, materials, and
transport simulations must be realized before even the first
prototype can be constructed, therefore, fabricating this device
from scratch can be a laborious task even after all of the fabri-
cation equipment and machinery has been procured. Despite all
of these issues, the authors were able to successfully inject both
ChR-2 and NpHR at multiple depths when inserting this micro-
fluidic-optrode hybrid. After six weeks of recovery, they were
able to optically stimulate brain cells with both 473-nm light and
593-nm light with output powers of 21 and 14 mW, respectively,
while concurrently recording neuronal activity changes.
The current paper focuses on the advances in device compo-
nents and functionality to illustrate the evolution of optogenetic
microdevices from simple tethered systems to novel wireless
devices. However, it is worth noting here that technologies
have not progressed solely in electrical components. Optical
fibers, for example, have also seen improvements recently,
such as the tapered optical fiber developed by Pisanello et al.72
This fiber allows for dynamic illumination control along each
taper, which acts as a window for light to escape from the
fiber. Tapers are formed by locally removing the coating at
each site where it is needed. This optical fiber technology allows
multiple areas of the brain to be selectively targeted by photo-
stimulation along the track of the optical fiber through the use of
a single light source. However, sophisticated calculations and
simulations are necessary to predictably deliver enough optical
power through the desired tapers.
3.2 Portable Microdevices
Although the technologies described thus far (summarized in
Table 2) represent significant serial improvements in research
since the inception of optogenetic devices, a critical factor
for device development is portability. Some of the previously
described optogenetic systems were only able to stimulate anes-
thetized animals while they lay motionless under stereotaxic
conditions, while other studies used tethered systems to allow
some movement. Acute stereotactic optogenetics studies may
be suitable for research on neural connectomics, but behavioral
experiments require free-moving animals, with minimal devia-
tions from the animals’ natural settings to gather relevant data.
Tethering the animal to the optogenetic system deviates from
this natural setting as it restricts home-cage activity, spontaneous
pain, wheel running, and freely moving social interactions.73
With emerging technologies allowing biomedical devices to
become smaller than previously imagined, researchers have
designed devices that are small enough to be implanted subcu-
taneously,57,74,75 some with only minor components exposed
externally. These implantable devices allow the animal to
perform measureable behavioral tasks while freely moving.
Affixing headstage devices or optical fibers and cannulas to
the animal requires the skull to be largely exposed during sur-
gery. This exposure allows for adequate anchoring of cranial
Table 2 Parameters of tethered systems. Blank fields indicate no information given.
Parameter Ref. 23 Ref. 58 Ref. 67 Ref. 69
LED pulse width 500 μs 20 ms 25 to 100 ms 300 μs
Pulse frequency 1 HZ 8 Hz 1 to 20 Hz 0.5 Hz
Wavelength 465 nm 473 nm 465 nm 474∕593 nm
Light output 29.6 mW 1.8 mW 25 mcd 21 mW∕14 mW
Electrode width 16 μm 200 μm 900 μm 250 μm
Power density 916 mW∕mm2 0.7 mW∕mm2
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screws and coverage of dental cement to ensure a strong bond is
formed, helping keep the fixtures attached to the skull. The large
surgical site, use of bonding cement, and drilling of cranial
screws increase the stress on the animal associated with surgery,
and should be minimized. Smaller and implantable devices help
minimize these issues; this is one advantage of miniaturizing
portable devices. Just as important, small devices give the ani-
mal less material to grab on-to during self-grooming. A problem
associated with animal termination from a study is the animal’s
ability to grab a device or electrode and forcibly detach it from
their skull. This leads to damage to the device, a loss of resour-
ces and time spent on surgery and treatments, and increase in
the risk of injury or death to the animal.
The ability to implant a microdevice with no bulky compo-
nents can remedy animal mortality rates. By eliminating the
battery and harvesting energy through alternative sources, newer
and smaller devices can be fabricated that are easier to imple-
ment in preclinical research. A small chip measuring <9 mm2,
constituting the bulk of the device, is an important aspect of the
device of Yeh et al.,74 as seen in Fig. 3(a). This is achievable
through electromagnetic (EM) midfield energy harvesting,
which the device gathers from an exposed coil measuring
only 3 mm2. This energy accumulates onto a capacitor to
power the LED. The source of this propagating field comes
from a circuit board transmitting 500 mW of power, which is
about the average power level of cell phones, to sustainably
power the receiving coil even at distances of 15 cm. This system
propagates energy in the gigahertz spectrum within a range that
is safe when absorbed by biological tissue. This desired fre-
quency range can be sufficiently estimated as a time scale of
the amplitude variation of the EM field falling largely between
upper-bound and lower-bound values. The upper-bound value is
represented by the dielectric relaxation time constant of the tis-
sue, and the lower-bound value is represented by the electric
time constant. Finding an ideal frequency range for energy
harvesting is vitally important for the animal’s wellbeing.
The animal’s wellbeing is scrutinized by institutional research
ethics committees, and impacts on animal welfare profoundly
affect experimental outcomes.76 Reported values for muscle
tissue electric time constant and dielectric relaxation time con-
stant are 2.3 ns and 7.2 ps, respectively, giving a safe midfield
frequency range between 690 MHz and 2.2 GHz. The Federal
Communications Commission mandates that the maximum
permissible exposure to radio frequency (RF) power for humans
in controlled environments is 3.03 mW∕cm2.77 Although this
particular device was developed to stimulate cardiac muscle
cells in mice, it could be modified for optogenetic stimulation
of neural tissue either directly by cortical stimulation or through
the use of a fiber-optic cord for modulations in deep regions.
Other wireless and battery-less devices that can take advan-
tage of power transmission are available. This concept is becom-
ing more critical in the medical device field because of the
inherent problems associated with thermodynamic chemical
reactions that occur in them, including having a slow recharging
rate of several hours, limited charge/discharge cycles, and being
a biohazard if toxic materials are leaked.79,80 Batteries that sus-
tain sufficiently long stimulation periods are inherently large
and heavy, thus battery-based devices can interfere with the
movements of animals. Therefore, it is beneficial to fabricate
smaller battery-less microdevices to power the LED, which
can have greater potential in recreating the animal’s natural envi-
ronment during photostimulation. One solution is substituting
battery charging with capacitor charging through energy trans-
mission as previously described. However, charging a capacitor
to deliver energy to the LED would require multiple stacked
capacitors to meet the high energy demands of most medical
devices. Whereas batteries have sufficiently high energy den-
sities, their power densities are relatively low, while capacitors
have much higher power densities but lack in energy density.81
In order to solve this issue, a middle-ground is necessary, and
one solution lies in the use of supercapacitors. Supercapacitors
can achieve power densities several orders of magnitude greater
than batteries.82 Meng et al.81 describe the fabrication of such
supercapacitors that are flexible, solid-state, and are only 1 mm2
in size, yet offer a high area of capacitance at 1.3 mF∕mm2.
They proposed combining the supercapacitor circuit with a
boost converter in order to minimize the current load on the
supercapacitor, which will then charge a regular capacitor that
regulates the power to the load.
Using a supercapacitor for miniature optogenetic devices
powered by RF has the potential to substantially advance current
behavioral research, enabling investigators to run multiple
Fig. 3 (a) Transmission coil and circuit board described by Yeh et al.74 on a penny for size comparison.
The tiny size of this system allows it to be implantable within the cranial skin of the animal. (b) The head-
stage and antenna developed by Wentz et al.43 (c) Headstage fabricated by Ameli et al.78 incorporating a
recording electrode. [Source: (a) is reprinted with permission from Yeh et al.74 Copyright 2013, AIP
Publishing LLC. (b) is reprinted with permission from Wentz et al.43 Copyright 2011, IOP Publishing.
All rights reserved. (c) is reprinted from Ameli et al.78 with permission from IEEE.]
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animal studies in parallel. Devices with these capabilities are
able to continuously transmit neurostimulation signals to a wear-
able or implanted optogenetic device while the animal is in its
home cage. As shown in Fig. 3(b), Wentz et al.43 have developed
such a device to demonstrate control of animal behaviors by
stimulating adult Thy-ChR2 transgenic mice pyramidal cells
of the motor cortex and analyzing subsequent rotational move-
ments. Their device incorporated a low-strength oscillating
magnetic field peaking at 300 A∕m to charge a supercapacitor,
and power a 1 × 1 mm2 LED with 2 W of power in steady state
and 4.3 W in burst LED. Although their experimental setup was
to stimulate cortical cells at the surface of the brain, their device
can be adapted with fiber-optic cords to stimulate deeper
regions. The whole device was fitted on a headstage that the
animal wears and totals just 2 g in weight. Additionally, this
device can be equipped with a 1 g wireless telemetry compo-
nent, such as light detection or thermal data, to output data
back to a computer. Throughout operation of the device, the ani-
mal is electrically insulated from the device components to
ensure safety. The device is also monitored for heat generation
from the LED and integrated circuit. The maximum temperature
rise in steady-state operation was 0.6°C, representing a worst
case scenario and well within a safe range.
One additional method to further advance an optogenetic
microdevice would be incorporating a recording electrode to
wirelessly send information back to a computer for stimulation
readouts. Ameli et al.78 have accomplished this task as shown in
Fig. 3(c). Using a fiber-optic cord concurrently with electrodes
coupled to a headstage device with a wireless signal rectifier,
their device incorporates many of the evolutionary advances
discussed throughout this review. Their device is relatively
heavy at 7.4 g, but implementing technological advances to
the device, such as smaller components and custom integrated
circuits, can solve this problem as discussed by the authors.
Nevertheless, the device is small at 15 × 25 × 17 mm3. The
transmitter can power the device up to 7 cm away and can trans-
mit data back to a base-station computer>2 m away. This makes
it ideal for running studies with multiple animals in individual
home cages receiving power through multiple transmission
sources and sending the information back to a central computer.
Although this device has not been tested in vivo, it demonstrates
promise that future iterations can be developed that are smaller
and robust.
Smaller components and devices are being progressively
implemented in more recent portable optogenetic devices.
Rossi et al.83 fitted their LED onto an optrode that can be
inserted into the brain. This allows experiments by this device
to be performed in deep brain regions without relying on optical
fibers. Although these LEDs are considered relatively large
compared to smaller μLEDs, this device represents a marked
improvement in portable devices compared to those previously
discussed. As can be seen in Table 3, this newer device is
smaller, lighter, and has a greater transmission range than other
devices. It does, however, require a battery to recharge the
device every 2 h, and other limitations exist, such as a lack
of recording features. One important advantage of this system
is that all of the components are commercially available and the
device can be constructed in any standard neuroscience lab. The
ability for most laboratories to construct their own device
becomes harder as the device dimensions are reduced, advanced
components and functions are utilized, and more fabrication
technologies are required.
3.3 Implantable Devices
Miniaturization of optogenetic devices is far from being com-
pletely realized, as newer classes of implantable optogenetic
systems are being introduced that are several orders of magni-
tude smaller in scale compared to early systems. Implantable
devices take advantage of μLEDs that are inserted into the
site of stimulation and are, therefore, less reliant on optical fibers
to deliver light. Optical fibers are typically able to illuminate
ventral structures from the fiber tip, whereas μLEDs have the
advantage of complete customizations, including the shape and
size of the photostimulation. μLEDs can come in a range of
sizes (625 to 10;000 μm2), can be fitted on a two-dimensional
array and spatially controlled for different illumination patterns,
and can output light in different directions using reflective
surfaces.73 Because of the low power demands of advanced
semiconductor μLEDs, power harvesting systems through radio-
frequency scavenging make it possible for an optogenetic
system to be at least partially implantable at the site of
Table 3 Transmission and device parameters of portable devices. Blank fields indicate no information given.
Parameter Ref. 74 Ref. 43 Ref. 78 Ref. 83 Refs. 73 and 84
LED wavelength 590∕630 nm 470 nm Various 465.5 nm Various
LED size Varies 1 × 1 mm Varies 240 × 320 × 140 μm 50 × 50 × 6.45 μm
Stimulation site Tissue surface Cortical surface Anywhere via optical fiber Anywhere via implant Anywhere via implant
Device dimensions 9 mm2 <1 cm3 15 × 25 × 17 mm 14 × 17 × 5 mm ∼1 cm3
Weight 2 g 7.4 g 2.9 g ∼2 g
Receiver frequency 1.6 GHz 2.4 to 2.485 GHz 868 MHz 2.4 to 2.5 GHz 910 MHz
Transmission range 15 cm Several cm <7 cm 4 m 1 to 2 m
Data rate 1 Mbit∕s 320 Kbit∕s 250 Kbit∕s
Power source EM midfield RF scavenging Inductive power Rechargeable battery RF scavenging
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stimulation. In partially implantable systems, only the power
harvesting components are exposed outside of the skull to effi-
ciently harness energy and ensure animal safety. An example of
implantable devices that use wireless energy harvesting is the
device developed by Kim et al.84 Through advanced microfab-
rication techniques as described in their protocol,73 their device
demonstrates how multiple components can be integrated onto
a miniature system. The system layers functional components
onto an injectable microneedle to conveniently implant the
optrode. The multitude of functions performed by this single
optrode include electrophysiological measurements (Pt-contact
pad, microelectrode), optical measurement (silicon μ-IPD), opti-
cal stimulation (μLED array), and temperature sensing (serpen-
tine Pt resistor). When dealing with functional components in
close proximity to internal tissue, thermal management is imper-
ative for the animal’s safety and it is important to measure the
temperature during device validation. Their device’s μLEDs
produced <0.10°C change in temperature, which is much
lower than the ∼2°C temperature change produced by deep
brain stimulation.85 At a distance of 1 m and a radio-frequency
scavenger output of 4.08 mW, the group was able to produce a
7 mW∕mm2 optical power output. The RF power that reaches
the animal at this distance is between 0.15 and 0.77 mW∕cm2,
much lower than the maximum permissible exposure limits for
humans. These cellular-scale μLEDs are only 6.45 μm thick and
50 × 50 μm2 in area, which are more than a thousand times
smaller than conventional LEDs. A collection of four μLEDs on
the single optrode was able to increase self-stimulated lever
presses by mice associated with dopamine release in the ventral
tegmental area.
Integration of μLEDs onto an array is a useful tool to pre-
cisely stimulate brain regions with complex shapes or topo-
graphic neuronal cell types. In such cases, having the ability
to target the region of interest without photostimulating other
regions allows researchers to control neuromodulation experi-
ments at the cellular scale. Grossman et al.33 implemented
4096 μLEDs, each only 20 μm in diameter, to create a
4 × 4 mm2 optogenetic array. Each 3 × 3 mm2 light spot created
by these μLEDs produces up to 3 mW∕mm2 optical power. With
lenses, this light spot can be demagnified by 10∶1 to produce
a 0.3 × 0.3 mm2 light spot with 300 mW∕mm2. Each one of
these μLEDs can be individually switched on or off and contain
different wavelength emitters for a broader range of opsin
activation. This capability also allows μLED arrays to activate
certain clusters of neural populations within regions, maximizing
activation precision. Research in sensory prosthetics and other
studies involving topographic regions of interest can benefit
from the cellular-scale precision offered by this device.
4 Conclusion
Advances in medical technology and fabrication techniques
have enabled brain research and increased the scope of potential
studies. New devices are constantly being developed and distrib-
uted for use by researchers. Tables 2 and 3 illustrate only a small
portion of important considerations in developing optogenetics
devices. Understanding the trends and advances is important for
designing improved systems for up-to-date research methods. A
device is within reach that would contain a modifiable LED
source, recording electrodes, and a microfluidics viral delivery
system all on a single optrode. The chip would be small enough
to sit on top of the skull yet be implanted under the skin and
incorporate a tiny rectenna that wirelessly powers the device,
transmits information, and alters the parameters in real time.
This way, animal behavior studies can be performed in large
scale and in parallel. This will enable researchers to better
understand the core neurobiology of diverse neurological and
psychiatric disorders, and facilitate the rational development of
treatments for wide-ranging neural syndromes, such as depres-
sion, epilepsy, Alzheimer’s disease, and more.
Acknowledgments
Michael Berk is supported by an NHMRC Senior Principal
Research Fellowship 1059660.
References
1. R. T. LaLumiere, “A new technique for controlling the brain: optoge-
netics and its potential for use in research and the clinic,” Brain Stimul.
4(1), 1–6 (2011).
2. K. Deisseroth, “Controlling the brain with light,” Sci. Am. 303(5), 48–55
(2010).
3. M. M. Sidor, “Psychiatry’s age of enlightenment: optogenetics and
the discovery of novel targets for the treatment of psychiatric disorders,”
J. Psychiatry Neurosci. 37(1), 4 (2012).
4. E. E. Steinberg and P. H. Janak, “Establishing causality for dopamine
in neural function and behavior with optogenetics,” Brain Res. 1511,
46–64 (2013).
5. A. V. Kravitz et al., “Regulation of Parkinsonian motor behaviours
by optogenetic control of basal ganglia circuitry,” Nature 466(7306),
622–626 (2010).
6. F. E. LeBeau, “Gamma oscillations and the cellular components of
consciousness?,” New Horiz. Neurosci. Conscious. 79, 29–37 (2010).
7. M. Berk and A. A. Nierenberg, “Three paths to drug discovery in
psychiatry,” Am. J. Psychiatry 172(5), 412–414 (2015).
8. M. Berk, “Pathways to new drug discovery in neuropsychiatry,” BMC
Med. 10(1), 151 (2012).
9. A. Kalueff, M. Wheaton, and D. Murphy, “What’s wrong with my
mouse model?: advances and strategies in animal modeling of anxiety
and depression,” Behav. Brain Res. 179(1), 1–18 (2007).
10. K. Deisseroth, “Optogenetics,” Nat. Methods 8(1), 26–29 (2011).
11. L. Madisen et al., “A toolbox of Cre-dependent optogenetic transgenic
mice for light-induced activation and silencing,” Nat. Neurosci. 15(5),
793–802 (2012).
12. B. Y. Chow et al., “High-performance genetically targetable optical neu-
ral silencing by light-driven proton pumps,” Nature 463(7277), 98–102
(2010).
13. J. Mattis et al., “Principles for applying optogenetic tools derived from
direct comparative analysis of microbial opsins,” Nat. Methods 9(2),
159–172 (2012).
14. G. Nagel et al., “Channelrhodopsin-2, a directly light-gated cation-
selective membrane channel,” Proc. Natl. Acad. Sci. 100(24), 13940–
13945 (2003).
15. A. M. Aravanis et al., “An optical neural interface: in vivo control of
rodent motor cortex with integrated fiberoptic and optogenetic technol-
ogy,” J. Neural Eng. 4(3), S143 (2007).
16. E. S. Boyden et al., “Millisecond-timescale, genetically targeted optical
control of neural activity,” Nat. Neurosci. 8(9), 1263–1268 (2005).
17. F. Zhang et al., “Red-shifted optogenetic excitation: a tool for fast neural
control derived from Volvox carteri,” Nat. Neurosci. 11(6), 631–633
(2008).
18. J. K. Lanyi et al., “The primary structure of a halorhodopsin from
Natronobacterium pharaonis. Structural, functional and evolutionary
implications for bacterial rhodopsins and halorhodopsins,” J. Biol.
Chem. 265(3), 1253–1260 (1990).
19. T. Vo-Dinh, Biomedical Photonics Handbook: Biomedical Diagnostics,
CRC Press (2014).
20. F. Bevilacqua et al., “In vivo local determination of tissue optical proper-
ties: applications to human brain,” Appl. Opt. 38(22), 4939–4950
(1999).
21. A. Yaroslavsky et al., “Optical properties of selected native and coagu-
lated human brain tissues in vitro in the visible and near infrared spectral
range,” Phys. Med. Biol. 47(12), 2059 (2002).
Neurophotonics 031206-9 Jul–Sep 2015 • Vol. 2(3)
Kale et al.: Evolution of optogenetic microdevices
Downloaded From: http://neurophotonics.spiedigitallibrary.org/ on 10/19/2015 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
22. R. L. Fork, “Laser stimulation of nerve cells in Aplysia,” Science
171(3974), 907–908 (1971).
23. I. P. Clements et al., “Miniaturized LED sources for in vivo optogenetic
experimentation,” Proc. SPIE 8586, 85860X (2013).
24. P. Degenaar et al., “Optobionic vision: a new genetically enhanced light
on retinal prosthesis,” J. Neural Eng. 6(3), 035007 (2009).
25. N. Grossman et al., “Modeling study of the light stimulation of a neuron
cell with channelrhodopsin-2 mutants,” IEEE Trans. Biomed. Eng.
58(6), 1742–1751 (2011).
26. F. Zhang et al., “Channelrhodopsin-2 and optical control of excitable
cells,” Nat. Methods 3(10), 785–792 (2006).
27. V. Gradinaru et al., “Optical deconstruction of Parkinsonian neural
circuitry,” Science 324(5925), 354–359 (2009).
28. A. R. Adamantidis et al., “Neural substrates of awakening probed with
optogenetic control of hypocretin neurons,” Nature 450(7168), 420–424
(2007).
29. X. Han et al., “Millisecond-timescale optical control of neural dynamics
in the nonhuman primate brain,” Neuron 62(2), 191–198 (2009).
30. V. Gradinaru et al., “Targeting and readout strategies for fast optical
neural control in vitro and in vivo,” J. Neurosci. 27(52), 14231–14238
(2007).
31. J. G. Bernstein et al., “Prosthetic systems for therapeutic optical acti-
vation and silencing of genetically targeted neurons,” Proc. SPIE 6854,
68540H (2008).
32. D. Huber et al., “Sparse optical microstimulation in barrel cortex drives
learned behaviour in freely moving mice,” Nature 451(7174), 61–64
(2008).
33. N. Grossman et al., “Multi-site optical excitation using ChR2 and
micro-LED array,” J. Neural Eng. 7(1), 016004 (2010).
34. N. Swann et al., “Deep brain stimulation of the subthalamic nucleus
alters the cortical profile of response inhibition in the beta frequency
band: a scalp EEG study in Parkinson’s disease,” J. Neurosci. 31(15),
5721–5729 (2011).
35. Y. Maegaki et al., “Somatosensory evoked high-frequency oscillations
recorded directly from the human cerebral cortex,” Clin. Neurophysiol.
111(11), 1916–1926 (2000).
36. D. S. Dinner et al., “EEG and evoked potential recording from the sub-
thalamic nucleus for deep brain stimulation of intractable epilepsy,”
Clin. Neurophysiol. 113(9), 1391–1402 (2002).
37. L. Rossi et al., “An electronic device for artefact suppression in human
local field potential recordings during deep brain stimulation,” J. Neural
Eng. 4(2), 96 (2007).
38. M. Filali et al., “Stimulation-induced inhibition of neuronal firing in
human subthalamic nucleus,” Exp. Brain Res. 156(3), 274–281 (2004).
39. K. C. McGill et al., “On the nature and elimination of stimulus artifact in
nerve signals evoked and recorded using surface electrodes,” IEEE
Trans. Biomed. Eng. BME-29(2), 129–137 (1982).
40. A. Kent and W. Grill, “Recording evoked potentials during deep brain
stimulation: development and validation of instrumentation to suppress
the stimulus artefact,” J. Neural Eng. 9(3), 036004 (2012).
41. J. G. Bernstein and E. S. Boyden, “Optogenetic tools for analyzing
theneural circuits of behavior,”TrendsCogn. Sci.15(12), 592–600 (2011).
42. J. A. Cardin et al., “Targeted optogenetic stimulation and recording
of neurons in vivo using cell-type-specific expression of
Channelrhodopsin-2,” Nat. Protoc. 5(2), 247–254 (2010).
43. C. T. Wentz et al., “A wirelessly powered and controlled device for
optical neural control of freely-behaving animals,” J. Neural Eng.
8(4), 046021 (2011).
44. S. S. Stensaas and L. Stensaas, “The reaction of the cerebral cortex to
chronically implanted plastic needles,” Acta Neuropathol. 35(3), 187–
203 (1975).
45. W. M. Grill, S. E. Norman, and R. V. Bellamkonda, “Implanted neural
interfaces: biochallenges and engineered solutions,” Annu. Rev. Biomed.
Eng. 11, 1–24 (2009).
46. M. E. Carter and L. de Lecea, “Optogenetic investigation of neural
circuits in vivo,” Trends Mol. Med. 17(4), 197–206 (2011).
47. B. McGovern et al., “A new individually addressable micro-LED array
for photogenetic neural stimulation,” IEEE Trans. Biomed. Circuits
Syst. 4(6), 469–476 (2010).
48. Y. Iwai et al., “A simple head-mountable LED device for chronic stimu-
lation of optogenetic molecules in freely moving mice,” Neurosci. Res.
70(1), 124–127 (2011).
49. A. G. Rays and C. S.-M. Fibers, “Fiber optics,” (1991).
50. S. J. Wetzel, “Coupling light emitting diodes to multimode optical
fibers,” 1993, http://preserve.lehigh.edu/cgi/viewcontent.cgi?article=
1165&context=etd (29 May 2015).
51. www.doriclenses.com.
52. G. D. Stuber et al., “Amygdala to nucleus accumbens excitatory trans-
mission facilitates reward seeking,” Nature 475(7356), 377 (2011).
53. F. Zhang et al., “Optogenetic interrogation of neural circuits: technology
for probing mammalian brain structures,” Nat. Protoc. 5(3), 439–456
(2010).
54. E. Martín-García et al., “New operant model of reinstatement of
food-seeking behavior in mice,” Psychopharmacol. 215(1), 49–70
(2011).
55. C. M. Olsen and D. G. Winder, “Operant sensation seeking engages
similar neural substrates to operant drug seeking in C57 mice,”
Neuropsychopharmacology 34(7), 1685–1694 (2009).
56. B. B. Land et al., “Optogenetic inhibition of neurons by internal light
production,” Front. Behav. Neurosci. 8 (2014).
57. D. C. Klorig and D. W. Godwin, “A magnetic rotary optical fiber
connector for optogenetic experiments in freely moving animals,”
J. Neurosci. Methods 227, 132–139 (2014).
58. J. Wang et al., “Integrated device for combined optical neuromodulation
and electrical recording for chronic in vivo applications,” J. Neural Eng.
9(1), 016001 (2012).
59. F. Hofmann and H. Bading, “Long term recordings with microelectrode
arrays: studies of transcription-dependent neuronal plasticity and axonal
regeneration,” J. Physiol.-Paris 99(2), 125–132 (2006).
60. F. Lanté et al., “Low-frequency stimulation induces a new form of LTP,
metabotropic glutamate (mGlu5) receptor-and PKA-dependent, in the
CA1 area of the rat hippocampus,” Hippocampus 16(4), 345–360
(2006).
61. J. Cang et al., “Development of precise maps in visual cortex requires
patterned spontaneous activity in the retina,” Neuron 48(5), 797–809
(2005).
62. S. J. Aton et al., “Vasoactive intestinal polypeptide mediates circadian
rhythmicity and synchrony in mammalian clock neurons,” Nat.
Neurosci. 8(4), 476–483 (2005).
63. E. Krook-Magnuson et al., “On-demand optogenetic control of sponta-
neous seizures in temporal lobe epilepsy,”Nat. Commun. 4, 1376 (2013).
64. J. T. Paz et al., “Closed-loop optogenetic control of thalamus as a tool
for interrupting seizures after cortical injury,” Nat. Neurosci. 16(1),
64–70 (2013).
65. C. Armstrong et al., “Closed-loop optogenetic intervention in mice,”
Nat. Protoc. 8(8), 1475–1493 (2013).
66. G. C. McConnell et al., “Implanted neural electrodes cause chronic,
local inflammation that is correlated with local neurodegeneration,”
J. Neural Eng. 6(5), 056003 (2009).
67. H. Cao et al., “An integrated μLED optrode for optogenetic stimulation
and electrical recording,” IEEE Trans. Biomed. Eng. 60(1), 225–229
(2013).
68. P. Anikeeva et al., “Optetrode: a multichannel readout for optogenetic
control in freely moving mice,” Nat. Neurosci. 15(1), 163–170
(2012).
69. B. Rubehn et al., “A polymer-based neural microimplant for optogenetic
applications: design and first in vivo study,” Lab Chip 13(4), 579–588
(2013).
70. R. Biran, D. C. Martin, and P. A. Tresco, “Neuronal cell loss accom-
panies the brain tissue response to chronically implanted silicon micro-
electrode arrays,” Exp. Neurol. 195(1), 115–126 (2005).
71. D. Szarowski et al., “Brain responses to micro-machined silicon devi-
ces,” Brain Res. 983(1), 23–35 (2003).
72. F. Pisanello et al., “Multipoint-emitting optical fibers for spatially
addressable in vivo optogenetics,” Neuron 82(6), 1245–1254 (2014).
73. J. G. McCall et al., “Fabrication and application of flexible, multimodal
light-emitting devices for wireless optogenetics,” Nat. Protoc. 8(12),
2413–2428 (2013).
74. A. J. Yeh et al., “Wirelessly powering miniature implants for optoge-
netic stimulation,” Appl. Phys. Lett. 103(16), 163701 (2013).
75. J. S. Ho et al., “Self-tracking energy transfer for neural stimulation in
untethered mice,” arXiv preprint arXiv:1503.01493 (2015).
76. J. Silverman, M. A. Suckow, and S. Murthy, The IACUC Handbook,
CRC Press (2014).
Neurophotonics 031206-10 Jul–Sep 2015 • Vol. 2(3)
Kale et al.: Evolution of optogenetic microdevices
Downloaded From: http://neurophotonics.spiedigitallibrary.org/ on 10/19/2015 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
77. F. C. Commission, “Guidelines for evaluating the environmental effects
of radiofrequency radiation,” 1996, https://transition.fcc.gov/Bureaus/
Engineering_Technology/Orders/1996/fcc96326.pdf (29 May 2015).
78. R. Ameli et al., “Awireless and batteryless neural headstage with optical
stimulation and electrophysiological recording,” in 2013 35th Annual
Int. Conf. of the IEEE, pp. 5662–5665 (2013).
79. R. J. Brodd et al., “Batteries, 1977 to 2002,” J. Electrochem. Soc.
151(3), K1–K11 (2004).
80. M. Armand and J.-M. Tarascon, “Building better batteries,” Nature
451(7179), 652–657 (2008).
81. C. Meng, O. Z. Gall, and P. P. Irazoqui, “A flexible super-capacitive
solid-state power supply for miniature implantable medical devices,”
Biomed. Microdevices 15(6), 973–983 (2013).
82. R. Sharpeshkar, “Ultra Low Power Bioelectronics: Fundamentals,
Biomedical Applications, and Bio-Inspired System,” Cambridge
University Press, Cambridge, UK (2010).
83. M. A. Rossi et al., “A wirelessly controlled implantable LED system
for deep brain optogenetic stimulation,” Front. Integr. Neurosci. 9, 8
(2015).
84. T.-I. Kim et al., “Injectable, cellular-scale optoelectronics with applica-
tions for wireless optogenetics,” Science 340(6129), 211–216 (2013).
85. M. M. Elwassif et al., “Bio-heat transfer model of deep brain stimula-
tion-induced temperature changes,” J. Neural Eng. 3(4), 306 (2006).
Rajas P. Kale is a PhD student in neural engineering at Deakin
University, Australia, and Mayo Clinic, USA. He received both his
bachelor in biomedical engineering and his bachelor of science in
neuroscience degrees from the University of Minnesota in 2010.
He is currently developing an optogenetic microdevice to be used
on small animals in preclinical models of mood disorder. His research
goal is to use novel neurostimulation techniques to expose important
biomarkers of neurodegenerative disorders.
Abbas Z. Kouzani received his PhD in electrical and electronics engi-
neering from Flinders University, Australia. Currently, he is an asso-
ciate professor with the School of Engineering, Deakin University.
He has been involved in over $2.4 million research grants and has
published over 250 refereed papers. His current research interests
include medical/biological microdevices, lab-on-a-chip systems, bio-
instrumentation, and biosensors and implants. He is the leader of
Deakin University’s BioMEMS Group.
Ken Walder is chair of metabolic diseases in the School of Medicine,
Deakin University and executive director of the Molecular and Medical
Research Strategic Research Centre. He has published over 70 peer-
reviewed research papers primarily in the field of metabolic diseases
and has been cited over 2000 times. The focus of his work is the dis-
covery and preclinical development of novel therapeutics for obesity
and type 2 diabetes.
Michael Berk is currently an NHMRC senior principal research fellow
and is Alfred Deakin chair of psychiatry at Deakin University, where he
heads the IMPACT Strategic Research Centre. He is past president of
the International Society for Bipolar Disorders and the Australasian
Society for Bipolar and Depressive Disorders. He has published
over 600 papers predominantly in the discovery and implementation
of novel therapies, and risk factors and prevention of psychiatric
disorders.
Susannah J. Tye received her PhD from the Departments of Psychol-
ogy and Biological Sciences, Macquarie University, Australia, in 2008.
She is now director of the Translational Neuroscience Laboratory at
the Mayo Clinic Depression Center. Her work aims to identify bio-
markers of neuropsychiatric disease and treatment response, and
translate findings into viable new treatment approaches. Her research
has actively contributed to development of animal models of stress-
induced depression, mania, and post-traumatic stress disorder.
Neurophotonics 031206-11 Jul–Sep 2015 • Vol. 2(3)
Kale et al.: Evolution of optogenetic microdevices
Downloaded From: http://neurophotonics.spiedigitallibrary.org/ on 10/19/2015 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
